|
Bristol-Myers Squibb announces new collaboration to evaluate combination therapy in colorectal cancer
|
05 June 2017 |
|
Array BioPharma and Bristol-Myers Squibb announce strategic collaboration
|
30 May 2017 |
|
Bristol-Myers Squibb enters into separate agreements with Biogen and Roche to License anti-eTau and anti-myostatin compounds
|
13 April 2017 |
|
The first overall survival data from the Phase 3 CheckMate -067 clinical trial
|
03 April 2017 |
|
Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute announce collaboration to accelerate immuno-oncology research
|
28 March 2017 |
|
Bristol-Myers Squibb expands focus on precision medicine with investment and planned collaboration with GRAIL
|
02 March 2017 |
|
Bristol-Myers Squibb expands International Immuno-Oncology Network (II-ON)
|
27 February 2017 |
|
Bristol-Myers Squibb appoints three new independent directors
|
21 February 2017 |
|
Bristol-Myers Squibb reports fourth quarter and full year 2016 financial results
|
26 January 2017 |
|
Bristol-Myers Squibb and GeneCentric Diagnostics announce exploratory biomarker research collaboration
|
10 January 2017 |
|
Bristol-Myers Squibb announces immunotherapy clinical collaboration with Janssen
|
05 January 2017 |
|
Bristol-Myers Squibb signs exclusive worldwide license agreement with PsiOxus Therapeutics
|
20 December 2016 |
|
Bristol-Myers Squibb strengthens capabilities with evolution of its U.S. geographic footprint
|
13 December 2016 |
|
Bristol-Myers Squibb reports third quarter results
|
27 October 2016 |
|
Bristol-Myers Squibb Foundation joins White House Cancer Moonshot
|
18 October 2016 |
|
Bristol-Myers Squibb and Nektar Therapeutics announce oncology clinical collaboration to evaluate the combination of Opdivo (nivolumab) and NKTR-214
|
27 September 2016 |
|
Bristol-Myers Squibb awards first "Golden Tickets" for LabCentral to PanTher, Suono Bio
|
20 September 2016 |
|
Bristol-Myers Squibb employees cycle Coast to Coast to raise money and awareness for cancer research
|
07 September 2016 |
|
Bristol-Myers Squibb reports second quarter financial results
|
29 July 2016 |
|
Bristol-Myers Squibb acquires Cormorant Pharmaceuticals
|
05 July 2016 |